
Amy K. Mottl
Nephrology · Unc Physicians and Associates
Credentials: · · ·
History
Research
JAMA · 2017 · 539 citations
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
New England Journal of Medicine · 2025 · 232 citations
Kidney International · 2015 · 158 citations

19 papers

19 papers

13 papers

13 papers

13 papers

12 papers
- JR
12 papers

12 papers
Grants
- 2022–2027
Geographic and Environmental Representation in Kidney Precision Medicine
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $2.1M · Univ of North Carolina Chapel Hill
- 2025–2027
National Institute of Diabetes and Digestive and Kidney Diseases · U34
PI · $733.4K · University of Minnesota
- 2021–2027
The Impact of Diabetes on Patients with Glomerular Disease: CureGN-Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $3.2M · Univ of North Carolina Chapel Hill
- 2012–2018
Phenotypes of Diabetic Kidney Disease and the Relationship to Retinal Pathology
National Institute of Diabetes and Digestive and Kidney Diseases · K23
Contact PI · $812.8K · Univ of North Carolina Chapel Hill
Clinical trials
- 2024–2027
The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
Principal investigator · Recruiting · Phase 2
University of North Carolina, Chapel Hill
- 2019–2027
- 2016–2027




